SCHEMBL9975181

SCHEMBL9975181

CC(C)CNc1nc(-c2ccc(N)cc2)cn2c(-c3ccc(C(=O)NC4CC4)cc3)cnc12

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15844113 0.96 TTK (0.93) TTK
SCHEMBL9940433 0.93 TTK (0.86) TTK
SCHEMBL9942248 0.93 TTK (0.86) TTK
SCHEMBL9936525 0.92 TTK (0.87) TTK
SCHEMBL9937981 0.92 TTK (0.87) TTK
SCHEMBL15844078 0.92 TTK (0.87) TTK
SCHEMBL9935008 0.92 TTK (0.87) TTK
SCHEMBL9942732 0.92 TTK (0.87) TTK
SCHEMBL9936310 0.92 TTK (1.00) TTK
SCHEMBL9935611 0.92 TTK (0.86) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012080230-A1 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 WO disclosed